Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Earnings Per Share, Basic and Diluted

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(61.6)	$	(15.7)	$	(121.6)	$	(55.6)
Less: amounts allocated to participating securities (1)	(10.0)		(9.1)		(29.2)		(26.4)
Net loss attributable to common stockholders	$	(71.6)	$	(24.8)	$	(150.8)	$	(82.0)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	48,883		48,310		48,736		48,265

Loss per share:
Basic and diluted (2)	$	(1.46)	$	(0.51)	$	(3.09)	$	(1.70)

Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
Stock options	810		—		285		—
Restricted shares	986		10		848		24

(1)Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.

(2)The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.